摘要
结核病是一个主要的杀手,尤其是艾滋病病毒感染者。由于耐多药和广泛耐药菌株的传播越来越广泛,使得这种疾病难以治疗是一个真正的医学需求。目前几乎所有药物均耐药的肺结核病例在世界各地以惊人的速度增长。在这里,我们回顾了目前在抗结核药物开发领域的知识,重点是药物的作用机制和有针对性的细菌细胞过程。特别强调的是细胞壁合成的过程,这已被证明为药物开发提供了强大的潜力。希望加深对重点分子机制的理解,将为我们提供更好的抗菌作用机制概况,为今后设计更有效的耐药结核病治疗策略提供线索。
关键词: 结核病,药物,蛋白质结构,结核病药物开发,细胞壁,抗菌。
Current Medicinal Chemistry
Title:Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall
Volume: 24 Issue: 36
关键词: 结核病,药物,蛋白质结构,结核病药物开发,细胞壁,抗菌。
摘要: Tuberculosis is a leading killer, especially for people living with HIV. It is a real medical need to tackle this disease, which is made difficult to treat due to the increasing spread of multi-drug-resistant and extensively drug-resistant bacterial strains. Cases of tuberculosis that are resistant to virtually all drugs currently available are increasing at an alarming rate around the world. Here, we review the current knowledge in the field of drug development against tuberculosis with a focus on the mechanisms of action of drugs and the targeted bacterial cell processes involved. Particular emphasis is dedicated to the process of cell wall synthesis, which has proven to provide strong potentialities for drug development. It is hoped that a deeper understanding of key molecular machineries to tackle will provide us with a better outline of possible antibacterial mechanisms of action and offer hints for the design of more efficient strategies to treat resistant tuberculosis in the future.
Export Options
About this article
Cite this article as:
Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall, Current Medicinal Chemistry 2017; 24 (36) . https://dx.doi.org/10.2174/0929867324666170208150016
DOI https://dx.doi.org/10.2174/0929867324666170208150016 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India
Cardiovascular & Hematological Agents in Medicinal Chemistry A Pathogenetic Approach to Autoimmune Skin Disease Therapy: Psoriasis and Biological Drugs, Unresolved Issues, and Future Directions
Current Pharmaceutical Design Cloning, Expression and Correlation of Rv0148 to Amikacin & Kanamycin Resistance
Current Proteomics Design, Synthesis and Cytotoxicity of Chalcone Analogs Derived from 2-Phenylimino-3-phenylthiazolidin-4-one
Letters in Drug Design & Discovery Immune Modulation by Regulatory T Cells in Helicobacter pylori-Associated Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry The First Years of Linezolid Experience in Clinical Practice: A Balance and Future Implications
Anti-Infective Agents in Medicinal Chemistry Natural Products Containing Olefinic Bond: Important Substrates for Semi-synthetic Modification Towards Value Addition
Current Organic Chemistry <i>In silico</i> Modeling of Antimalarial Protein Kinase Inhibitors
Letters in Drug Design & Discovery Simultaneous Modeling of Antimycobacterial Activities and ADMET Profiles: A Chemoinformatic Approach to Medicinal Chemistry
Current Topics in Medicinal Chemistry An Efficient Gram Scale Synthesis of Aryl Iodides from Aryl Diazofluoroborates in Water under Mild Conditions
Letters in Organic Chemistry HIV Type 1 Subtype A1 Dominates in Armenia
Current HIV Research Synthesis and Biological Evaluation of Coumarin Linked Fluoroquinolones, Phthalimides and Naphthalimides as Potential DNA Gyrase Inhibitors
Letters in Drug Design & Discovery Novel Information about Neisseria meningitidis: Identification of the Most Important Type II Toxin Antitoxin Systems
Infectious Disorders - Drug Targets Drug-Induced Peripheral Neuropathy: Diagnosis and Management
Current Cancer Drug Targets Use of Peptide Libraries for Identification and Optimization of Novel Antimicrobial Peptides
Current Topics in Medicinal Chemistry Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design Understanding Mass Spectrometry-based Global Mycobacterial Lipidomics
Current Molecular Medicine From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology Autoimmune Diseases in Gastroenterology
Current Pharmaceutical Design